Recursion Pharmaceuticals Inc (RXRX)
5.695
-0.06
(-0.96%)
USD |
NASDAQ |
Nov 22, 16:00
5.74
+0.04
(+0.79%)
After-Hours: 16:52
Recursion Pharmaceuticals Price to Book Value: 3.112 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.142 |
| November 20, 2024 | 3.300 |
| November 19, 2024 | 3.426 |
| November 18, 2024 | 3.333 |
| November 15, 2024 | 3.374 |
| November 14, 2024 | 3.776 |
| November 13, 2024 | 4.00 |
| November 12, 2024 | 4.142 |
| November 11, 2024 | 4.284 |
| November 08, 2024 | 3.880 |
| November 07, 2024 | 3.787 |
| November 06, 2024 | 3.809 |
| November 05, 2024 | 3.727 |
| November 04, 2024 | 3.628 |
| November 01, 2024 | 3.497 |
| October 31, 2024 | 3.454 |
| October 30, 2024 | 3.644 |
| October 29, 2024 | 3.677 |
| October 28, 2024 | 3.748 |
| October 25, 2024 | 3.535 |
| October 24, 2024 | 3.469 |
| October 23, 2024 | 3.453 |
| October 22, 2024 | 3.606 |
| October 21, 2024 | 3.688 |
| October 18, 2024 | 3.786 |
| Date | Value |
|---|---|
| October 17, 2024 | 3.573 |
| October 16, 2024 | 3.824 |
| October 15, 2024 | 3.638 |
| October 14, 2024 | 3.666 |
| October 11, 2024 | 3.611 |
| October 10, 2024 | 3.371 |
| October 09, 2024 | 3.355 |
| October 08, 2024 | 3.513 |
| October 07, 2024 | 3.371 |
| October 04, 2024 | 3.330 |
| October 03, 2024 | 3.303 |
| October 02, 2024 | 3.330 |
| October 01, 2024 | 3.363 |
| September 30, 2024 | 3.592 |
| September 27, 2024 | 3.371 |
| September 26, 2024 | 3.462 |
| September 25, 2024 | 3.327 |
| September 24, 2024 | 3.303 |
| September 23, 2024 | 3.221 |
| September 20, 2024 | 3.284 |
| September 19, 2024 | 3.351 |
| September 18, 2024 | 3.337 |
| September 17, 2024 | 3.264 |
| September 16, 2024 | 3.211 |
| September 13, 2024 | 3.173 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.756
Minimum
May 11 2022
10.83
Maximum
Jul 13 2021
4.256
Average
3.904
Median
Aug 10 2022
Price to Book Value Benchmarks
| Revance Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 3.142 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.361 |
| Theriva Biologics Inc | 0.1457 |
Price to Book Value Related Metrics
| PS Ratio | 21.66 |
| PEG Ratio | -0.5960 |
| Price | 5.695 |
| Earnings Yield | -27.22% |
| Market Cap | 1.632B |
| PEGY Ratio | -0.5960 |